Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Further studies are needed to address the role of estrogen receptor beta in breast cancer
November 3rd, 2005
A multicenter investigation aimed at reaching a consensus on the immunohistochemical detection of estrogen receptor (ER) beta in archival formalin-fixed paraffin embedded human breast tissue determined that further studies are needed. According to a study from England, "ER alpha is a well-established independent prognostic factor in breast cancer whose presence determines the clinical implications of adjuvant endocrine therapy. A second receptor, ER beta has been described, and a number of studies have examined its expression in breast tissue." "However elucidation of the role played by ER beta has been hampered by published immunohistochemical...
Source: Women's Health Weekly (2005-11-03)
|
